Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis
Hui Ding, Minyao Xie, Jinyi Wang, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 185-195
Closed Access | Times Cited: 16

Showing 16 citing articles:

Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders
Brittany A. Blose, Adriann Lai, Christen Crosta, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1316-1324
Open Access | Times Cited: 13
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
Chuanjun Zhuo, Qiuyu Zhang, Lina Wang, et al.
CNS Drugs (2023) Vol. 38, Iss. 1, pp. 33-44
Open Access | Times Cited: 12
Genetic Nurture Effects on Type 2 Diabetes Among Chinese Han Adults: A Family-Based Design
Xiaoyi Li, Zechen Zhou, Yujia Ma, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 120-120
Open Access
Genetic Susceptibility to Depression is Associated with Increased Risk of Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of 38 Mendelian Randomisation Studies
Tabinda Jabeen, Emma Todd, Sarah Gauci, et al.
(2025)
Closed Access
Clinical Characterisation of the Co-Occurrence of Mental and Physical Disorders
R. I. G. Holt
(2025), pp. 127-160
Closed Access
Eating disorders: etiology, risk factors, and suggestions for prevention
Anna Keski‐Rahkonen
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 6, pp. 381-387
Closed Access | Times Cited: 3
Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches
M. Natividad, Mary V. Seeman, Jennipher Paola Paolini, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1238-1238
Open Access | Times Cited: 7
Neuronal alterations in AKT isotype expression in schizophrenia
Emily A. Devine, Ali Sajid Imami, Hunter Eby, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 2
Neuronal alterations in AKT isotype expression in schizophrenia
Robert E. McCullumsmith, Ali Sajid Imami, Hunter Eby, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Risk cycling in diabetes and autism spectrum disorder: a bidirectional Mendelian randomization study
Yunfeng Yu, Xinyu Yang, Gang Hu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Pilot Study of Personalized Transcranial Magnetic Stimulation with Spectral Electroencephalogram Analyses for Assessing and Treating Persons with Autism
Milan Makale, Chad Nybo, Kenneth Blum, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 857-857
Open Access | Times Cited: 1
Pilot Study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, and ABCB1 Gene Expression in Peripheral Blood Leukocytes in Schizophrenic Patients with Metabolic Syndrome
Anastasiia S. Boiko, Diana Z. Paderina, Ekaterina V. Mikhalitskaya, et al.
Neurochemical Journal (2024) Vol. 18, Iss. 1, pp. 29-35
Open Access
Pilot study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, ABCB1 genes expression in peripheral blood leukocytes in schizophrenic patients with metabolic syndrome
Anastasiia S. Boiko, Diana Z. Paderina, Ekaterina V. Mikhalitskaya, et al.
Нейрохимия (2024) Vol. 41, Iss. 1
Closed Access
Transforming the diabetes outcomes for people with mental illness
R. I. G. Holt
Practical Diabetes (2024) Vol. 41, Iss. 4, pp. 3-8
Open Access
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs.
Edward J. Modestino, Abdalla Bowirrat, David Baron, et al.
PubMed (2024) Vol. 8, Iss. 1, pp. 34-49
Closed Access
Neuronal alterations in AKT isotype expression in schizophrenia
Emily A. Devine, Alex Joyce, Ali Sajid Imami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top